Bicycle Therapeutics 過去の業績
過去 基準チェック /06
Bicycle Therapeuticsの収益は年間平均-35.1%の割合で減少していますが、 Biotechs業界の収益は年間 増加しています。収益は年間19% 31.2%割合で 増加しています。
主要情報
-35.1%
収益成長率
-10.2%
EPS成長率
| Biotechs 業界の成長 | 17.0% |
| 収益成長率 | 31.2% |
| 株主資本利益率 | -19.0% |
| ネット・マージン | -450.6% |
| 前回の決算情報 | 30 Sep 2024 |
最近の業績更新
Recent updates
Bicycle Therapeutics plc (NASDAQ:BCYC) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Nov 03
Bicycle Therapeutics (NASDAQ:BCYC) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Oct 23Bicycle Therapeutics Is Looking Increasingly Attractive
Aug 20Bicycle Therapeutics Boosts Balance Sheet To Navigate Data Desert
May 24Shareholders May Not Be So Generous With Bicycle Therapeutics plc's (NASDAQ:BCYC) CEO Compensation And Here's Why
May 10Analysts' Revenue Estimates For Bicycle Therapeutics plc (NASDAQ:BCYC) Are Surging Higher
May 04Does Bicycle Therapeutics (NASDAQ:BCYC) Have A Healthy Balance Sheet?
Apr 19Bicycle: 2nd Half Of 2024 Data Could Provide Significant Inflection Point
Mar 12Bicycle Therapeutics (NASDAQ:BCYC) Is Using Debt Safely
Jan 04Newsflash: Bicycle Therapeutics plc (NASDAQ:BCYC) Analysts Have Been Trimming Their Revenue Forecasts
Nov 07The Bicycle Therapeutics plc (NASDAQ:BCYC) Analysts Have Been Trimming Their Sales Forecasts
May 14Industry Analysts Just Upgraded Their Bicycle Therapeutics plc (NASDAQ:BCYC) Revenue Forecasts By 26%
Mar 31Is Bicycle Therapeutics (NASDAQ:BCYC) Using Debt In A Risky Way?
Mar 09Time To Worry? Analysts Just Downgraded Their Bicycle Therapeutics plc (NASDAQ:BCYC) Outlook
Nov 08Bicycle Therapeutics: Exploring An Intriguing Developmental Platform
Oct 08Bicycle Therapeutics initiated Outperform at Cowen citing drug platform
Aug 31Bicycle to get $10M as Genentech uses option for new program under cancer drug collaboration
Jul 12Is Bicycle Therapeutics (NASDAQ:BCYC) Weighed On By Its Debt Load?
Jul 10Bicycle Therapeutics: Promising Early-Stage Cancer Drug Developer
Jul 05Bicycle Therapeutics: Trying To Catch This Falling Knife
Apr 17Is Bicycle Therapeutics (NASDAQ:BCYC) A Risky Investment?
Apr 11Bicycle Therapeutics: A Buy Ahead Of AACR Presentation
Mar 25Bicycle Therapeutics: An Oncology Play With Big Potential
Feb 28Bicycle Therapeutics (NASDAQ:BCYC) Has Debt But No Earnings; Should You Worry?
Nov 07Bicycle Therapeutics: Scaffolding Short Linear Peptides Into Bicycles
Aug 25The Consensus EPS Estimates For Bicycle Therapeutics plc (NASDAQ:BCYC) Just Fell Dramatically
Aug 07News Flash: Analysts Just Made A Sizeable Upgrade To Their Bicycle Therapeutics plc (NASDAQ:BCYC) Forecasts
May 08収支内訳
収支内訳
Bicycle Therapeutics の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Sep 24 | 37 | -166 | 65 | 0 |
| 30 Jun 24 | 40 | -165 | 62 | 0 |
| 31 Mar 24 | 42 | -168 | 62 | 0 |
| 31 Dec 23 | 27 | -181 | 60 | 0 |
| 30 Sep 23 | 25 | -162 | 59 | 0 |
| 30 Jun 23 | 23 | -140 | 52 | 0 |
| 31 Mar 23 | 15 | -124 | 48 | 0 |
| 31 Dec 22 | 14 | -113 | 50 | 0 |
| 30 Sep 22 | 15 | -101 | 50 | 0 |
| 30 Jun 22 | 16 | -87 | 48 | 0 |
| 31 Mar 22 | 14 | -78 | 42 | 0 |
| 31 Dec 21 | 12 | -67 | 32 | 0 |
| 30 Sep 21 | 12 | -66 | 35 | 0 |
| 30 Jun 21 | 11 | -62 | 34 | 0 |
| 31 Mar 21 | 11 | -56 | 32 | 0 |
| 31 Dec 20 | 10 | -51 | 29 | 0 |
| 30 Sep 20 | 12 | -38 | 22 | 0 |
| 30 Jun 20 | 9 | -37 | 19 | 0 |
| 31 Mar 20 | 9 | -35 | 16 | 0 |
| 31 Dec 19 | 14 | -31 | 15 | 0 |
| 30 Sep 19 | 10 | -33 | 13 | 0 |
| 30 Jun 19 | 11 | -31 | 11 | 0 |
| 31 Mar 19 | 11 | -26 | 10 | 0 |
| 31 Dec 18 | 7 | -22 | 8 | 0 |
| 30 Sep 18 | 7 | -21 | 9 | 0 |
| 31 Dec 17 | 2 | -16 | 6 | 0 |
質の高い収益: BCYCは現在利益が出ていません。
利益率の向上: BCYCは現在利益が出ていません。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: BCYCは利益が出ておらず、過去 5 年間で損失は年間35.1%の割合で増加しています。
成長の加速: BCYCの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。
収益対業界: BCYCは利益が出ていないため、過去 1 年間の収益成長をBiotechs業界 ( -2.3% ) と比較することは困難です。
株主資本利益率
高いROE: BCYCは現在利益が出ていないため、自己資本利益率 ( -19.03% ) はマイナスです。